CSPC Pharmaceutical nine-month net profit doubles to 7.08bn yuan
石药集团9个月净利润70.8亿元人民币,上年同期35.1亿元人民币;营收252.6亿元人民币;每股收益0.6199元人民币。
CSPC is one of the larger Hong Kong-listed Chinese drugmakers.
CSPC Pharmaceutical Group reported net profit of 7.08bn yuan for the first nine months, up from 3.51bn yuan a year earlier, according to Wallstreetcn. Revenue was 25.26bn yuan and earnings per share 0.6199 yuan.